Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
Scott Ripley
Advertisement
Scott Ripley is the general manager, nucleic acid, for Cytiva.
Articles by Scott Ripley
Advertisement
Latest Updated Articles
Advertisement
Advertisement